EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population

John E Hughes iD, Frank Moriarty iD, Kathleen E Bennett iD, Caitriona Cahir iD

British Journal of Clinical Pharmacology · 2024-04 · 90 (4) · 959-975

DOI: 10.1111/bcp.15970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 26.12.2023. Verfasst von John E Hughes und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: Quality of Life, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Health Research Board, Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The aims of this study were to estimate potentially clinically important drug–drug interaction (DDI) prevalence, and the average causal effect of DDI exposure on adverse drug reaction (ADR)‐related hospital admission, and to examine differences in health‐related quality of life (HRQoL) and length of stay (LOS) per DDI exposure in an older (≥65 years) population acutely hospitalized.

Methods

This was a cross‐sectional study conducted among 798 older individuals acutely admitted to hospital in Ireland between 2016 and 2017. Medication (current/recently discontinued/over‐the‐counter) and clinical data (e.g., creatinine clearance) were available. DDIs were identified using the British National Formulary (BNF) and Stockley's Drug Interactions . Causal inference models for DDI exposure on ADR‐related hospital admission were developed using directed acyclic graphs. Multivariable logistic regression was used to estimate the average causal effect. Differences in HRQoL (EQ‐5D) and LOS per DDI exposure were examined non‐parametrically. DDI prevalence, adjusted odds ratios (aOR), and 95% confidence intervals (CIs) are reported.

Results

A total of 782 (98.0%) individuals using two or more drugs were included. Mean age was 80.9 (SD ± 7.5) years (range: 66–105); 52.2% were female; and 45.1% ( n = 353) had an ADR‐related admission. At admission, 316 (40.4% [95% CI: 37.0–43.9]) patients had at least one DDI. The average causal effect of DDI exposure on ADR‐related hospital admission was aOR = 1.21 [95% CI: 0.89–1.64]. This was significantly increased by exposure to: DDIs which increase bleeding risk (aOR = 2.00 [1.26–3.12]); aspirin‐warfarin (aOR = 2.78 [1.37–5.65]); and esomeprazole‐escitalopram (aOR = 3.22 [1.13–10.25]. DDI‐exposed patients had lower HRQoL (mean EQ‐5D = 0.49 [±0.39]) compared those non‐DDI‐exposed (mean EQ‐5D = 0.57 [±0.41]), ( P = .03); and greater median LOS in hospital (8 [IQR5–16]days) compared those non‐DDI‐exposed (7 [IQR 4–14] days),( P = .04).

Conclusions

Potentially clinically important DDIs carry an increased average causal effect on ADR‐related admission, significantly (two‐fold) by exposure to DDIs that increase bleeding risk, which should be targeted for medicine optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeDrug-Related Side Effects and Adverse ReactionsHumansFemaleAged, 80 and overMaleCross-Sectional StudiesDrug InteractionsHospitals

Stichwörter der Autor:innen

adverse drug reactionscausal Bayesian networkscausal inferencedirected acyclic graphsdrug interactionsmedication safetypharmacoepidemiology

Autor:innen und Institutionen

  • School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Data Science Centre, School of Population Health, RCSI University of Medicine and Health Sciences, Dublin, Ireland.

ORCID-Profile: John E Hughes, Frank Moriarty, Kathleen E Bennett, Caitriona Cahir

Förderung

  • Health Research Board
  • Irish Research Council

Zitieren

APA

Hughes, J. E., Moriarty, F., Bennett, K. E., & Cahir, C. (2024). Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population. British Journal of Clinical Pharmacology, 90(4), 959-975. https://doi.org/10.1111/bcp.15970

Vancouver

Hughes JE, Moriarty F, Bennett KE, Cahir C. Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population. British Journal of Clinical Pharmacology. 2024;90(4):959-975. doi:10.1111/bcp.15970

BibTeX
@article{Hughes2024,
  author = {Hughes, John E and Moriarty, Frank and Bennett, Kathleen E and Cahir, Caitriona},
  title = {Drug–drug interactions and the risk of adverse drug reaction‐related hospital admissions in the older population},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  volume = {90},
  number = {4},
  pages = {959--975},
  doi = {10.1111/bcp.15970}
}
Kostenlos starten →